J&J Can't Revive Claims Against Abbott, Boston Sci

By Abigail Rubenstein

Law360, New York (February 18, 2010, 3:02 PM ET) -- A federal judge has ruled that Johnson & Johnson cannot amend its complaint to resurrect its breach of contract and anti-competitive conduct claims against Abbott Laboratories and Boston Scientific Corp. in a $5.5 billion suit over its failed bid to acquire Guidant Corp.

Judge Richard J. Sullivan of the U.S. District Court for the Southern District of New York on Wednesday denied the medical giant's motion for leave to amend the complaint, rejecting its attempt to reassert tortious interference claims against Abbott and Boston Scientific and...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles